Bayer Gets FDA Nod On First Quantitative Test For HCV Viral Load
This article was originally published in The Gray Sheet
Executive Summary
Bayer Diagnostics will launch its Versant quantitative branch DNA assay for hepatitis-C virus RNA in May to U.S. clinical and molecular labs, pathologists and physicians. The test received PMA approval April 3